Dimethyldioxirane → (E)-9,10-dehydroepothilone B

HRID 254459

반응식

CC1(C)OO1.[CH3:6][C@@H:7]1[C@H:25]([OH:26])[C@@H:24]([CH3:27])[C:22](=[O:23])[C:21]([CH3:29])([CH3:28])[C@@H:20]([OH:30])[CH2:19][C:17](=[O:18])[O:16][C@H:15](/[C:31](/[CH3:39])=[CH:32]/[C:33]2[N:37]=[C:36]([CH3:38])[S:35][CH:34]=2)[CH2:14][C@@H:12]2[O:13][C@:11]2([CH3:40])[CH2:10][CH2:9][CH2:8]1>>[CH3:6][C@@H:7]1[C@H:25]([OH:26])[C@@H:24]([CH3:27])[C:22](=[O:23])[C:21]([CH3:28])([CH3:29])[C@@H:20]([OH:30])[CH2:19][C:17](=[O:18])[O:16][C@H:15](/[C:31](/[CH3:39])=[CH:32]/[C:33]2[N:37]=[C:36]([CH3:38])[S:35][CH:34]=2)[CH2:14][C@@H:12]2[O:13][C@:11]2([CH3:40])[CH2:10][CH:9]=[CH:8]1

참가 물질

반응물 2

HCID 115197Dimethyldioxirane

HCID 448013Epothilone B

생성물 1

HCID 25264146(E)-9,10-dehydroepothilone B수율 87%

실험 절차

We considered whether the incorporation of C9-C10 olefin in epothilone B (51, EpoB) would alter its biological profile in the same direction as was the case with its 12,13 desoxy counterparts. Toward this end, we studied the epoxidation of 28 with 2,2′-dimethydroxirane (DMDO). The reaction indeed proceeded with high chemoselectively at the more substituted C12-C13 olefin. There was obtained an 87% yield of a 1:2.6 ratio of the (E)-9,10-dehydroepothilone B (49) and its diastereomer bearing the α-12,13-oxirane (structure not shown). In vitro studies with 49 (whose configurations at C12 and C13 was established by its reduction to afford Epo B) revealed it to be roughly 2-4 fold more potent than the parent EpoB (51) in various cell lines. While compound 49 proved to be the most potent epothilone we encountered in our program, its narrow therapeutic index in xenografts, as well as its difficult accessibility (vide supra) served to discourage further its pre-clinical development. Interestingly, the unnatural α-oxirane was virtually devoid of activity.

후처리

customThe reaction

출처 및 근거

ORD 기록: ord-fb97510ac92b46ef8b7707016c162c8d
출처 데이터셋: uspto-grants-2011_01
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US07875638B2

연결된 노트

불러오는 중…